Long-term Impact and Intervention for Diarrhea in Brazil

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

321 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-06-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objectives of this study are to determine the effect of 1 year supplementation of Vitamin A, Zinc, and Vitamin A plus Zinc compared to placebo on the Height for Age Z Score (HAZ) and the number of episodes of diarrhea and number of days of diarrhea at one year in children living in a Brazilian slum. Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. There is also a sub study to determine if ten days of glutamine delivered as an oral bolus improves the health of the digestive system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study on Immunological Effect of Vitamin A and Zinc in a Placebo Controlled 4 Cell Trial

NCT00374023

Immunity Diarrhea Respiratory Tract Infections

COMPLETED NA

Effect of Zinc and Vitamin A Supplementation on Diarrhea, Physical Growth and Immune Response in Malnourished Children

NCT00272116

Diarrhea Pneumonia Acute Respiratory Tract Infection

COMPLETED NA

Trends Over Time (1990-2010) of Diarrhoea-related Hospitalizations and Deaths in Children < 5 Years of Age in Brazil

NCT01175252

Diarrhoea Gastroenteritis

COMPLETED

Zinc Supplementation and Severe and Recurrent Diarrhea

NCT01306097

Diarrhea

COMPLETED NA

Oral Zinc for the Treatment of Acute Diarrhea in US Children

NCT01198587

Diarrhea Gastroenteritis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. Subjects will be enrolled into this prospective, randomized, placebo controlled study of the Long-term Impact and Intervention for Diarrhea in Brazil. Children meeting the inclusion criteria will be prospectively, randomized to four arms: (1) placebo: placebo (2) Vitamin A: Zinc Placebo (3) Vitamin A Placebo:Zinc (4) Vitamin A:Zinc. Intervention will last for one year with two additional years of follow up. A nested study involving all patients will take place at week four. At week four there will be a second randomization to either oral glutamine or glycine (placebo) for an additional ten days. The primary endpoint of the nested study will be the L:M ratio at 6 weeks. The master randomization list will be broken, only by combined approval of the Principal Investigators, at the end of the study or in the unexpected event of a child needing removal from the study (for that case only). All randomized subjects will be visited in their home two times per week for assessment of intercurrent diarrhea. At 1, 4, 8, 12, 24 and 36 months patients will have a nutritional status/anthropometry and diarrheal illness rate assessment. At 0, 1, 1.5, and 4 months all randomized subjects will have a Lactulose:Mannose Ratio (L:M) performed. A blood Zinc and Vitamin A level will be drawn at 0 and 4 months. Also a stool microbiology, lactoferrin and protein loss assessment will be completed at 1 month. All randomized subjects who complete the protocol should have assessments as outlined above at 36 weeks. The primary effect of interest is the difference in mean HAZ changes between children receiving Zinc plus Vitamin A compared to children receiving no Vitamin A or Zinc, averaging the difference in children receiving glutamine and children not receiving glutamine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diarrheal Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

a

oral glutamine with juice for 10 days

Group Type EXPERIMENTAL

Glutamine

Intervention Type DRUG

0.8gm/kg, ie up to a total daily dose of 16.2gm/day,with juice daily for 10 days

b

PO vit A q 4 mo for 1 year plus zinc placebo

Group Type EXPERIMENTAL

Vitamin A

Intervention Type DRUG

100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.

zinc

Intervention Type DRUG

40 mg twice weekly for 12 months

c

Zinc 40 mg twice weekly Plus Vitamin A Placebo for one year

Group Type ACTIVE_COMPARATOR

Vitamin A

Intervention Type DRUG

100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.

zinc

Intervention Type DRUG

40 mg twice weekly for 12 months

d

oral glycine with juice daily for 10 days

Group Type PLACEBO_COMPARATOR

glycine

Intervention Type DRUG

0.4gm/kg; ie up to 8.3gm/d, with juice daily for 10 days

e

Vitamin A Placebo plus Zinc Placebo for one year

Group Type PLACEBO_COMPARATOR

Vitamin A

Intervention Type DRUG

100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.

zinc

Intervention Type DRUG

40 mg twice weekly for 12 months

f

Vitamin A q 4 months and PO Zinc for 1 year

Group Type EXPERIMENTAL

Vitamin A

Intervention Type DRUG

100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.

zinc

Intervention Type DRUG

40 mg twice weekly for 12 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glutamine

0.8gm/kg, ie up to a total daily dose of 16.2gm/day,with juice daily for 10 days

Intervention Type DRUG

Vitamin A

100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.

Intervention Type DRUG

glycine

0.4gm/kg; ie up to 8.3gm/d, with juice daily for 10 days

Intervention Type DRUG

zinc

40 mg twice weekly for 12 months

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Children ages 2 months to 8 years with height for age Z-score (HAZ) less than the median for the Parque Universitario community. Be a resident in Brazilian flavela. Child's parent or guardian must sign informed consent.

Exclusion Criteria

Children exclusively breast-fed. Children who participated in the "hospital study" or any other study with in the past two years. Children with fever \> 102 F at time of screening. Children with systemic disease at the time of screening including but not limited to: shock, meningitis, sepsis, pneumonia, tuberculosis, varicella. Children on antibiotics during screening. Children with siblings from the same household enrolled in this study.

Minimum Eligible Age

2 Months

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No